PARATEK PHARMACEUTICALS INC
PARATEK PHARMACEUTICALS INC
Action · US6993743029 · PRTK · A12EGE (XNMS)
Aperçu Indicateurs financiers
Pas de cours
n/a

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
- - - - 0,00 % 0,00 % -54,58 %

Profil de l'entreprise pour PARATEK PHARMACEUTICALS INC Action

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co., Ltd. and Allergan plc; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and contract with Biomedical Advanced Research and Development Authority to support the development of NUZYRA for the treatment of pulmonary anthrax. In addition, it has license agreement with Tetraphase Pharmaceuticals, Inc. to develop, import, and sell the XERAVATM product, which is used for the treatment of complicated intra-abdominal infections caused by bacteria. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.

Fonds investis

Les fonds suivants ont investi dans : PARATEK PHARMACEUTICALS INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
7,95
Part (%)
0,02 %

Données de l'entreprise

Nom PARATEK PHARMACEUTICALS INC
Société Paratek Pharmaceuticals, Inc.
Symbole PRTK
Site web https://paratekpharma.com
Marché d'origine XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A12EGE
ISIN US6993743029
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dr. Evan Loh FACC, FAHA, M.D.
Capitalisation boursière 128 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,3 T
Adresse 75 Park Plaza, 02116 Boston
Date d'introduction en bourse 2009-02-03
Dividendes de 'PARATEK PHARMACEUTICALS INC'
Date ex-dividende Dividende par action
31.10.2014 0,06 USD
22.10.2014 0,67 USD
04.06.2014 1,33 USD
21.05.2014 1,33 USD

Fractionnements d'actions

Date Fractionnement
31.10.2014 1:12

Changements d'identifiant

Date De À
30.10.2014 TSPT PRTK

Symboles boursiers

Nom Symbole
NASDAQ PRTK

Autres actions

Les investisseurs qui détiennent PARATEK PHARMACEUTICALS INC ont également les actions suivantes dans leur portefeuille :
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
AUTOMATIC DATA PROCESSING INC
AUTOMATIC DATA PROCESSING INC Action
CARDLYTICS INC
CARDLYTICS INC Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COMCAST CORP - CLASS A
COMCAST CORP - CLASS A Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
HCI GROUP INC DL
HCI GROUP INC DL Action
HONEYWELL INTERNATIONAL INC
HONEYWELL INTERNATIONAL INC Action
INTEL CORP
INTEL CORP Action
LBBW NACHHALTIGKEIT AKT.I
LBBW NACHHALTIGKEIT AKT.I Fonds
MICROSOFT CORP
MICROSOFT CORP Action
MoonLake Immunotherapeutics - Class A Ordinary Shares
MoonLake Immunotherapeutics - Class A Ordinary Shares Action
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025